Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Industrial and Microbial Biotechnology >> Biocatalysis and Enzyme Biotechnology >>Operating Strategy

Operating Strategy
An operating strategy also need to be prepared for the use of immobilized enzymes to have maximum production at minimum cost. Since the enzyme activity falls down in due course of time, the production rate also falls. This is minimized by (i) using a multiple reactor system, in which start-up and reloading time for each reactor is staggered with other reactors in series or parallel (as done in case of glucose isomerase), and by (ii) raising temperature to compensate for loss in activity (as has been done for lactase).

The operating costs have to be kept in mind, while deciding about the operating mind, while deciding about the operating strategies and will include cost of the following: (i) immobilized enzymes (including carrier system, immobilization equipment, etc.); (ii) labour (including fringe benefits, supervision and other overhead expenses); (iii) depreciation charges of the equipment used, which may be upto 20% of the capital annually and (iv) raw material losses at each processing step.

Regulatory considerations
For using immobilized enzymes, particularly for producing food or pharmaceuticals, it is necessary to get approval of appropriate authority (e.g. Food and Drug Administration or FDA in USA) for the use of a particular fixing agent or a carrier system. These fixing agents have to be declared safe by these authorities. Only two fixing agents for glucose isomerase are approved and these are (i) diethylaminoethyl cellulose and (ii) glutaraldehyde. Many of the fixing agents reported in literature are not 'approved for use in food industry.

 

Left Right